Trials / Conditions / Sickle Cell-Beta0-Thalassemia
Sickle Cell-Beta0-Thalassemia
3 registered clinical trials studyying Sickle Cell-Beta0-Thalassemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Isoquercetin in Sickle Cell Anemia NCT04474626 | Jeffrey Zwicker, MD | Phase 2 |
| Active Not Recruiting | Epidemiology of Silent and Overt Strokes in Sickle Cell Disease NCT03376893 | Vanderbilt University Medical Center | — |
| Completed | The Effect of Rivaroxaban in Sickle Cell Disease NCT02072668 | University of North Carolina, Chapel Hill | Phase 2 |